This study will investigate a new drug called Infacort®; a newly-developed immediate release
formulation of a well-established drug called hydrocortisone. Hydrocortisone is used as a
replacement treatment for people whose adrenal glands are not producing enough natural
cortisol - a condition known as adrenal insufficiency. The study will assess how Infacort®
acts once inside the body, by measuring cortisol and other hormone levels in the body,
compared to already marketed hydrocortisone tablet and hydrocortisone intravenous (through
the vein) injection.
The population who are eligible to take part in the study are healthy male volunteers, aged
between 18 and 60 years of age.